My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2021/364 of 26 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product-type 1 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2021/364 of 26 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product-type 1 (Text with EEA relevance)

Implementing Regulation (EU) 2021/364 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Active chlorine generated from sodium chloride by electrolysis is approved as an active substance for use in biocidal products of product-type 1 subject to the specifications and conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Active chlorine generated from sodium chloride by electrolysis IUPAC name: not applicable EC No: not applicable CAS No: not applicable Precursor: IUPAC Name: Sodium Chloride EC No 231-598-3 CAS No 7647-14-5 The specifications for active chlorine generated from sodium chloride by electrolysis in situ are dependent on the precursor sodium chloride which must comply with purity requirements of one of the following standards: NF Brand, EN 973 A, EN 973 B, EN 14805 Type 1, EN 14805 Type 2, EN 16370 Type 1, EN 16370 Type 2, EN 16401 Type 1, EN 16401 Type 2, CODEX STAN 150-1985 or European Pharmacopoeia 9.0. 1 July 2021 30 June 2031 1 The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance. ( 1 )   The purity requirements for the precursor indicated in this column are those provided in the application for the approval of the active substance evaluated.

Other acts of the same type
Council Implementing Regulation (EU) 2018/137 of 29 January 2018 implementing Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in TunisiaCouncil Regulation (EU) 2018/147 of 29 January 2018 amending Regulation (EU) No 1370/2013 as regards the quantitative limitation for buying-in skimmed milk powderCommission Delegated Regulation (EU) 2018/561 of 29 January 2018 amending Delegated Regulation (EU) 2016/127 with regard to protein requirements for follow-on formula (Text with EEA relevance. )Regulation (EU) 2018/231 of the European Central Bank of 26 January 2018 on statistical reporting requirements for pension funds (ECB/2018/2)Commission Implementing Regulation (EU) 2018/128 of 25 January 2018 correcting certain language versions of Implementing Regulation (EU) 2015/504 implementing Regulation (EU) No 167/2013 of the European Parliament and of the Council with regard to the administrative requirements for the approval and market surveillance of agricultural and forestry vehicles (Text with EEA relevance. )Commission Implementing Regulation (EU) 2018/129 of 25 January 2018 concerning the authorisation of L-arginine produced by Corynebacterium glutamicum KCCM 80099 as a feed additive for all animal species (Text with EEA relevance. )Commission Implementing Regulation (EU) 2018/130 of 25 January 2018 concerning the authorisation of a preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Trichoderma reesei (BCCM/MUCL 49755) as a feed additive for pigs for fattening (holder of authorisation Berg and Schmidt GmbH Co. KG) (Text with EEA relevance. )Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 renewing the approval of the low-risk active substance laminarin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 renewing the approval of the active substance acetamiprid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2018/125 of 24 January 2018 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs TariffCommission Implementing Regulation (EU) 2018/126 of 24 January 2018 amending Council Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in LibyaCommission Implementing Regulation (EU) 2018/127 of 24 January 2018 amending Regulation (EC) No 1484/95 as regards fixing representative prices in the poultrymeat and egg sectors and for egg albumin

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next